| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Mirati Therapeutics Inc (NASDAQ: MRTX)
MRTX Technical Analysis
5
| As on 9th Jun 2023 MRTX STOCK Price closed @ 37.98 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 81.39 & Strong Sell for SHORT-TERM with Stoploss of 117.54 we also expect STOCK to react on Following IMPORTANT LEVELS. |
MRTXSTOCK Price
| Open | 38.82 | Change | Price | % |
| High | 38.91 | 1 Day | -0.73 | -1.89 |
| Low | 37.82 | 1 Week | -0.48 | -1.25 |
| Close | 37.98 | 1 Month | -5.27 | -12.18 |
| Volume | 996258 | 1 Year | -106.98 | -73.80 |
| 52 Week High 152.00 | 52 Week Low 36.54 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| MRTX Daily Charts |
MRTX Intraday Charts |
Whats New @ Bazaartrend |
MRTX Free Analysis |
|
|
MRTX Important Levels Intraday
| RESISTANCE | 40.08 |
| RESISTANCE | 39.41 |
| RESISTANCE | 38.99 |
| RESISTANCE | 38.57 |
| SUPPORT | 37.39 |
| SUPPORT | 36.97 |
| SUPPORT | 36.55 |
| SUPPORT | 35.88 |
MRTX Forecast April 2024
| 4th UP Forecast | 125.14 |
| 3rd UP Forecast | 97.19 |
| 2nd UP Forecast | 79.91 |
| 1st UP Forecast | 62.63 |
| 1st DOWN Forecast | 13.33 |
| 2nd DOWN Forecast | -3.95 |
| 3rd DOWN Forecast | -21.23 |
| 4th DOWN Forecast | -49.18 |
MRTX Weekly Forecast
| 4th UP Forecast | 59.97 |
| 3rd UP Forecast | 52.92 |
| 2nd UP Forecast | 48.56 |
| 1st UP Forecast | 44.20 |
| 1st DOWN Forecast | 31.76 |
| 2nd DOWN Forecast | 27.40 |
| 3rd DOWN Forecast | 23.04 |
| 4th DOWN Forecast | 15.99 |
MRTX Forecast2024
| 4th UP Forecast | 271.55 |
| 3rd UP Forecast | 196.64 |
| 2nd UP Forecast | 150.34 |
| 1st UP Forecast | 104.04 |
| 1st DOWN Forecast | -28.08 |
| 2nd DOWN Forecast | -74.38 |
| 3rd DOWN Forecast | -120.68 |
| 4th DOWN Forecast | -195.59 |
Mirati Therapeutics Inc ( NASDAQ USA Symbol : MRTX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
MRTX Business Profile
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase I/II clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; and Sitravatinib, an investigational spectrum-selective kinase inhibitor that is in Phase II clinical trial for the treatment of NSCL cancer, as well as a KRAS G12D inhibitor program, which is in preclinical development. It has a collaboration and license agreement with BeiGene, Ltd. to develop, manufacture, and commercialize sitravatinib; and a clinical collaboration agreement with Novartis Pharmaceuticals Corporation. Mirati Therapeutics, Inc. was founded in 1995 and is headquartered in San Diego, California. Address: 3545 Cray Court, San Diego, CA, United States, 92121
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service